121 related articles for article (PubMed ID: 33326338)
1. Do We Conform with European Glaucoma Society Guidelines in the Medical Treatment of Primary Open-Angle Glaucoma/Ocular Hypertension? Data from a Real-Life Practice.
Alagöz N; Tellioglu A; Bektasoglu DL; Yasar T; Basgil Pasaoglu I; Altan AC; Solmaz B; Basarır B
J Ocul Pharmacol Ther; 2020 Dec; 36(10):747-753. PubMed ID: 33326338
[No Abstract] [Full Text] [Related]
2. Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization.
Trese MGJ; Lewis AW; Blachley TS; Stein JD; Moroi SE
J Ocul Pharmacol Ther; 2017 Oct; 33(8):591-597. PubMed ID: 28854348
[TBL] [Abstract][Full Text] [Related]
3. Geographical variation in glaucoma prescribing trends in England 2008-2012: an observational ecological study.
Heng JS; Wormald R; Khaw PT
BMJ Open; 2016 May; 6(5):e010429. PubMed ID: 27188806
[TBL] [Abstract][Full Text] [Related]
4. Prescribing Trends in a Glaucoma Clinic and Adherence to EGS Guidelines: A Retrospective, Non-Interventional, Single-Center UK Study.
Fajgenbaum M; Ansari E
Adv Ther; 2017 Aug; 34(8):2033-2042. PubMed ID: 28726170
[TBL] [Abstract][Full Text] [Related]
5. Treatment of glaucoma patients with insufficient intraocular pressure control: a survey of German ophthalmologists in private practice.
Vorwerk C; Thelen U; Buchholz P; Kimmich F
Curr Med Res Opin; 2008 May; 24(5):1295-301. PubMed ID: 18366862
[TBL] [Abstract][Full Text] [Related]
6. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France].
Bron A; Nordmann JP; Baudouin C; Rouland JF; Kadi A; Sartral M
J Fr Ophtalmol; 2003 Nov; 26(9):895-903. PubMed ID: 14631273
[TBL] [Abstract][Full Text] [Related]
7. [The glaucoma pharmacological treatment and biomechanical properties of the cornea].
Liehneová I; Karlovská S
Cesk Slov Oftalmol; 2014 Oct; 70(5):167-76. PubMed ID: 25640039
[TBL] [Abstract][Full Text] [Related]
8. Association of ocular hypotensive medication types with dynamic contour tonometry and Goldmann applanation tonometry measurements in a glaucoma and ocular hypertensive population.
Tzamalis A; Kynigopoulos M; Chalvatzis N; Dimitrakos S; Schlote T
J Ocul Pharmacol Ther; 2013 Feb; 29(1):41-7. PubMed ID: 23066787
[TBL] [Abstract][Full Text] [Related]
9. Compliance With Primary Open-angle Glaucoma and Primary Open-angle Glaucoma Suspect Preferred Practice Patterns in a Retail-based Eye Clinic.
Stanley J; Huisingh CE; Swain TA; McGwin G; Owsley C; Girkin CA; Rhodes LA
J Glaucoma; 2018 Dec; 27(12):1068-1072. PubMed ID: 30234750
[TBL] [Abstract][Full Text] [Related]
10. Comparison of resident and glaucoma faculty practice patterns in the care of open-angle glaucoma.
Zebardast N; Solus JF; Quigley HA; Srikumaran D; Ramulu PY
BMC Ophthalmol; 2015 Apr; 15():41. PubMed ID: 25879212
[TBL] [Abstract][Full Text] [Related]
11. Glaucoma care and conformance with preferred practice patterns. Examination of the private, community-based ophthalmologist.
Hertzog LH; Albrecht KG; LaBree L; Lee PP
Ophthalmology; 1996 Jul; 103(7):1009-13. PubMed ID: 8684788
[TBL] [Abstract][Full Text] [Related]
12. Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence.
Kuwayama Y; Hashimoto M; Kakegawa R; Nomura A; Shimada F
Adv Ther; 2017 Jun; 34(6):1411-1425. PubMed ID: 28502035
[TBL] [Abstract][Full Text] [Related]
13. The Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics.
Konstantakopoulou E; Gazzard G; Vickerstaff V; Jiang Y; Nathwani N; Hunter R; Ambler G; Bunce C;
Br J Ophthalmol; 2018 May; 102(5):599-603. PubMed ID: 28982956
[TBL] [Abstract][Full Text] [Related]
14. Understanding the treatment paradigm and the sequencing of antiglaucoma fixed-dose combinations in a tertiary center in South India.
George R; Mishra P; Shantha B; Vijaya L; Maksane N; Gurha N
Indian J Ophthalmol; 2024 Jun; 72(6):896-901. PubMed ID: 38623708
[TBL] [Abstract][Full Text] [Related]
15. Resident compliance with the american academy of ophthalmology preferred practice pattern guidelines for primary open-angle glaucoma.
Ong SS; Sanka K; Mettu PS; Brosnan TM; Stinnett SS; Lee PP; Challa P
Ophthalmology; 2013 Dec; 120(12):2462-2469. PubMed ID: 23916487
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial.
DuBiner HB; Mroz M; Shapiro AM; Dirks MS;
Clin Ther; 2001 Dec; 23(12):1969-83. PubMed ID: 11813932
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Generic Latanoprost Versus Branded Prostaglandin Analogs for Primary Open Angle Glaucoma.
Kim DH; Addis VM; Pan W; VanderBeek BL
Ophthalmic Epidemiol; 2019 Feb; 26(1):63-71. PubMed ID: 30188773
[TBL] [Abstract][Full Text] [Related]
18. One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension.
Tanihara H; Inoue T; Yamamoto T; Kuwayama Y; Abe H; Fukushima A; Suganami H; Araie M;
Acta Ophthalmol; 2016 Feb; 94(1):e26-34. PubMed ID: 26338317
[TBL] [Abstract][Full Text] [Related]
19. [Management of ocular hypertension and chronic open-angle glaucoma by French ophthalmologists: the role of target intraocular pressure].
Laplace O; Bron A; Nordmann JP
J Fr Ophtalmol; 2006 Apr; 29(4):353-8. PubMed ID: 16885801
[TBL] [Abstract][Full Text] [Related]
20. Conformance with preferred practice patterns in caring for patients with glaucoma.
Albrecht KG; Lee PP
Ophthalmology; 1994 Oct; 101(10):1668-71. PubMed ID: 7936565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
